There are 2 tests required to diagnose alpha-1 antitrypsin deficiency. The first test is an alpha-1 antitrypsin (AAT) level, the second more informative test is an AAT phenotype. An AAT phenotype is the definitive test for AAT deficiency as it precisely identifies the type of AAT protein present in the blood, for example Z or S. Ordering an AAT level will measure how much of this protein is in the blood and is a useful screening tool, for example in the setting of COPD. However, this test does not provide a definitive diagnosis. This is because AAT is an acute phase protein (like CRP) and can be elevated during infection and inflammation. If you have a strong suspicion of AAT deficiency in your patient, or if there is a family history of AAT deficiency, order both AAT level and AAT phenotype.
The World Health Organisation (WHO), American Thoracic Society (ATS), and European Respiratory Society (ERS) together recommend the following cohorts for screening;
COPD, regardless of age or smoking history
Severe, non-responsive/refractory asthma
Cryptogenic liver disease
All first-degree relatives of people with diagnosed AAT deficiency
Individuals with reduced serum levels of AAT
Panniculitis
Sample Requirements
We require 1 serum or plasma sample – the minimum volume required is 3.0 mls. The blood sample should be carefully labelled with name, DOB, etc. and sent to:
Alpha-1 Foundation Ireland, RCSI Smurfit Building, Beaumont Hospital, Dublin 9.
What Happens Next
The blood sample can be sent directly to Alpha-1 Foundation Ireland where the test is performed. Results of the test are then returned to the requesting doctor in approximately 2-3 weeks. If the request is urgent, please let us know and we will do our best to accelerate testing.
Should you have any further questions please contact us on 01-8093871 or email alpha1@rcsi.ie.
Info Centre
WhatisAlpha-1Antitrypsin?
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test.
WhatisAlpha-1AntitrypsinDeficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, after cystic fibrosis, is the commonest genetic disorder in Ireland. It severely affects more than 15,000 people, with another 250,000 carriers also at risk of lung and liver disease on the island of Ireland. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
HowDoIGetTested?
The Alpha-1 Foundation Ireland provides free testing for Alpha-1 as part of a national screening programme which is funded by the HSE. It is a simple blood test. For more details ring 01-8093871 or email alpha1@rcsi.ie
Testing Criteria
Tests Required
There are 2 tests required to diagnose alpha-1 antitrypsin deficiency. The first test is an alpha-1 antitrypsin (AAT) level, the second more informative test is an AAT phenotype. An AAT phenotype is the definitive test for AAT deficiency as it precisely identifies the type of AAT protein present in the blood, for example Z or S. Ordering an AAT level will measure how much of this protein is in the blood and is a useful screening tool, for example in the setting of COPD. However, this test does not provide a definitive diagnosis. This is because AAT is an acute phase protein (like CRP) and can be elevated during infection and inflammation. If you have a strong suspicion of AAT deficiency in your patient, or if there is a family history of AAT deficiency, order both AAT level and AAT phenotype.
For more information on testing see “Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians” published in the Lancet Respiratory Medicine in 2019.
Who Should be Tested?
The World Health Organisation (WHO), American Thoracic Society (ATS), and European Respiratory Society (ERS) together recommend the following cohorts for screening;Sample Requirements
We require 1 serum or plasma sample – the minimum volume required is 3.0 mls. The blood sample should be carefully labelled with name, DOB, etc. and sent to: Alpha-1 Foundation Ireland, RCSI Smurfit Building, Beaumont Hospital, Dublin 9.What Happens Next
The blood sample can be sent directly to Alpha-1 Foundation Ireland where the test is performed. Results of the test are then returned to the requesting doctor in approximately 2-3 weeks. If the request is urgent, please let us know and we will do our best to accelerate testing. Should you have any further questions please contact us on 01-8093871 or email alpha1@rcsi.ie.Info Centre
What is Alpha-1 Antitrypsin?
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test.
What is Alpha-1 Antitrypsin Deficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, after cystic fibrosis, is the commonest genetic disorder in Ireland. It severely affects more than 15,000 people, with another 250,000 carriers also at risk of lung and liver disease on the island of Ireland. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
How Do I Get Tested?
The Alpha-1 Foundation Ireland provides free testing for Alpha-1 as part of a national screening programme which is funded by the HSE. It is a simple blood test. For more details ring 01-8093871 or email alpha1@rcsi.ie